CRWD vs NOW: Which Is the Better Buy?

Side-by-side comparison of CrowdStrike Holdings, Inc. and ServiceNow, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
CrowdStrike Holdings, Inc. Β· Technology
$259.67
-13.1% upside to fair value
Low Conviction Grade C High Quality
VS
ServiceNow, Inc. Β· Technology
$139.82
+16.2% upside to fair value
Med Conviction Grade A- High Quality
QuantHub Verdict
NOW has more upside to fair value (+16.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRWD NOW
Current Price $259.67 $139.82
Fair Value Estimate $225.56 $162.50
Upside to Fair Value -13.1% +16.2%
Market Cap $264.4B $144.6B
Forward P/E β€” β€”
EV / EBITDA 595.7x 43.1x
Price / Sales 49.0x 9.8x
Price / FCF 167.9x 31.5x
Revenue Growth YoY +25.8% +24.0%
Gross Margin 75.2% 74.8%
Operating Margin -2.2% 11.4%
Return on Equity 1.3% 13.8%
Dividend Yield 0% 0%
FCF Yield 0.6% 3.17%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
CRWD β€” CrowdStrike Holdings, Inc.
CrowdStrike Holdings is a cloud-native cybersecurity platform company that sells subscriptions to its Falcon platform and a growing array of cloud modules spanning endpoint protection, cloud workload security, identity protection, Next-Gen SIEM, threat intelligence, and managed services, generating revenue through a direct sales force and channel partners from its Austin, Texas headquarters with …
NOW β€” ServiceNow, Inc.
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
Accumulation Zones
Metric CRWD NOW
Zone Low $169.17 $121.88
Zone High $191.73 $138.12
In Buy Zone? No No
← CRWD Research    NOW Research β†’    All Research